의약품 부작용의 심각도 조사 비교분석Measuring the Seriousness of Adverse Drug Reactions : Comparisons between Korean Experts and WHO Working Group Members
- Other Titles
- Measuring the Seriousness of Adverse Drug Reactions : Comparisons between Korean Experts and WHO Working Group Members
- Authors
- 이진이; 박세영; 허지행; 박미혜; 하지혜; 이의경
- Issue Date
- Oct-2011
- Publisher
- 한국임상약학회
- Keywords
- adverse drug reaction; seriousness; Delphi technique; Korea; WHO
- Citation
- 한국임상약학회지, v.21, no.3, pp 237 - 242
- Pages
- 6
- Journal Title
- 한국임상약학회지
- Volume
- 21
- Number
- 3
- Start Page
- 237
- End Page
- 242
- URI
- https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/6910
- ISSN
- 1226-6051
- Abstract
- This study measures seriousness of adverse drug reactions (ADRs) among Korean physicians and pharmacists using two times surveys based on Delphi technique. Each participant scored 20 ADR terms on a scale of one to ten (10 being the most serious). We repeated the exercise for the 49 first survey respondents and 32 re-evaluated score. We compared the results of our survey with those of WHO CIOMS (Council for International Organization of Medical Sciences) working groups members conducted in 1995. The overall mean ADR seriousness score was 6.49 for Koreans and 5.12 for WHO CIOMS members, presenting Korean experts perceived more seriously for each ADR. Mean score changes for the same respondents showed similar trends regardless of access to the first survey results. There were no statistically significant score differences between the physicians and the pharmacists. The high consensus of seriousness for each ADR between the Korean experts and the WHO CIOMS members implies that the similar results are reproducible, suggesting the possibility of developing standardized tools for measuring the seriousness of individual ADRs in the future.
- Files in This Item
-
Go to Link
- Appears in
Collections - 특수대학원 > 임상약학대학원 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.